Controlling the entire cell therapy production process—from material receipt to product release—is “essential,” according to AstraZeneca, which says its new $300 million manufacturing facility will be ...

The investment strengthens Maryland’s position as a biotech hub and reflects AstraZeneca’s commitment to local job creation ...

GSK has been ramping up its manufacturing for Benlysta in anticipation of the new approval, including in-house capacity at its Rockville ... phase 3 AURORA trial. AstraZeneca wasn’t so fortunate ...

AstraZeneca Plc lost its crown as the UK’s most valuable listed company after US President Donald Trump’s plans to lower drug prices sent shares of pharmaceuticals companies lower across the ...

As health systems across the Middle East and Africa confront the dual pressures of rising non-communicable diseases (NCDs) and persistent access gaps, AstraZeneca is placing health equity at the ...

A ceremony marking the start of construction on AstraZeneca's new small molecule drug factory is held in Wuxi, East China's Jiangsu province, on May 8. [Photo provided to chinadaily.com.cn ...

AstraZeneca and Honeywell are developing MDIs that will use a new propellant called HFO-1234ze, which, according to the company, has 99.9% less Global Warming Potential (GWP) than existing ...

AstraZeneca starts at 23.1 times in 2025 and gradually falls to 16.6 times by 2027. This indicates the market expects solid growth from AstraZeneca. GSK, on the other hand, has a much lower P/E ...